Non Small Cell Lung Cancer

Showing NaN - NaN of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022

Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +4 more
  • Aurora, Colorado
  • +2 more
Apr 18, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Nivolumab
  • +8 more
  • Glendale, Arizona
  • +135 more
Feb 28, 2022

Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

Terminated
  • Non Small Cell Lung Cancer
  • Houston, Texas
  • +12 more
Jan 31, 2022

Melanoma, Non Small Cell Lung Cancer Trial in United States (enoblituzumab plus ipilimumab)

Completed
  • Melanoma
  • Non Small Cell Lung Cancer
  • enoblituzumab plus ipilimumab
  • Los Angeles, California
  • +9 more
Feb 4, 2022

Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +12 more
  • Nashville, Tennessee
  • +4 more
Feb 3, 2022

Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • GRT-C901
  • +3 more
  • Phoenix, Arizona
  • +10 more
Aug 31, 2021

Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in United States (ZN-c3)

Recruiting
  • Solid Tumor
  • +9 more
  • Tucson, Arizona
  • +3 more
Aug 12, 2021

Non Small Cell Lung Cancer Trial in Worldwide (OSE2101, Docetaxel, Pemetrexed)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Burbank, California
  • +76 more
Mar 5, 2021

Non Small Cell Lung Cancer, Cancer Trial in United States (Venetoclax, Pembrolizumab)

Terminated
  • Non Small Cell Lung Cancer
  • Cancer
  • Birmingham, Alabama
  • +38 more
Feb 10, 2021

Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Pembrolizumab)

Terminated
  • Non Small Cell Lung Cancer
  • Huntsville, Alabama
  • +73 more
Jan 15, 2021

Non Small Cell Lung Cancer Trial in Worldwide (RAD001, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Atlanta, Georgia
  • +13 more
Dec 17, 2020

Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Nivolumab)

Terminated
  • Non Small Cell Lung Cancer
  • Tempe, Arizona
  • +34 more
Aug 22, 2020

Non Small Cell Lung Cancer Trial in France, Spain, United States (AC0010MA)

Terminated
  • Non Small Cell Lung Cancer
  • Duarte, California
  • +7 more
Oct 28, 2019

Detecting EGFR T790M Mutations From Circulating Tumor Cells

Completed
  • Non Small Cell Lung Cancer
  • Circulating tumor cell chip
  • Boston, Massachusetts
  • +3 more
Sep 23, 2016

Non Small Cell Lung Cancer Trial in Worldwide (ARQ 197, Erlotinib, Placebo)

Completed
  • Non Small Cell Lung Cancer
  • ARQ 197
  • +2 more
  • Burbank, California
  • +37 more
Feb 22, 2013

Non Small Cell Lung Cancer Trial in Australia, Germany, United States (RAD001)

Completed
  • Non Small Cell Lung Cancer
  • Washington, District of Columbia
  • +7 more
Feb 9, 2013

Non Small Cell Lung Cancer Trial in Canada, United States (Pemetrexed, Cetuximab, Docetaxel)

Completed
  • Non Small Cell Lung Cancer
  • Birmingham, Alabama
  • +66 more
Sep 13, 2012